vs
Side-by-side financial comparison of Sunshine Biopharma Inc. (SBFM) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.
Spire Global, Inc. is the larger business by last-quarter revenue ($15.8M vs $8.6M, roughly 1.8× Sunshine Biopharma Inc.). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -176.6%, a 151.7% gap on every dollar of revenue. On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -26.9%). Sunshine Biopharma Inc. produced more free cash flow last quarter ($-1.6M vs $-16.2M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -32.6%).
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.
SBFM vs SPIR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $15.8M |
| Net Profit | $-2.1M | $-28.0M |
| Gross Margin | 35.3% | 40.2% |
| Operating Margin | -20.9% | -164.1% |
| Net Margin | -25.0% | -176.6% |
| Revenue YoY | -10.6% | -26.9% |
| Net Profit YoY | 0.8% | 42.7% |
| EPS (diluted) | — | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | $15.8M | ||
| Q3 25 | $9.4M | $12.7M | ||
| Q2 25 | $9.4M | $19.2M | ||
| Q1 25 | $8.9M | $23.9M | ||
| Q4 24 | $9.6M | $21.7M | ||
| Q3 24 | $8.4M | $28.6M | ||
| Q2 24 | $9.3M | $25.4M | ||
| Q1 24 | $7.5M | $34.8M |
| Q4 25 | $-2.1M | $-28.0M | ||
| Q3 25 | $-883.8K | $-19.7M | ||
| Q2 25 | $-1.8M | $119.6M | ||
| Q1 25 | $-1.2M | $-20.7M | ||
| Q4 24 | $-2.2M | $-48.8M | ||
| Q3 24 | $-1.2M | $-12.5M | ||
| Q2 24 | $-494.3K | $-16.6M | ||
| Q1 24 | $-1.3M | $-25.5M |
| Q4 25 | 35.3% | 40.2% | ||
| Q3 25 | 32.6% | 36.6% | ||
| Q2 25 | 36.4% | 48.9% | ||
| Q1 25 | 30.7% | 36.8% | ||
| Q4 24 | 32.2% | 32.4% | ||
| Q3 24 | 34.0% | 44.5% | ||
| Q2 24 | 25.3% | 43.0% | ||
| Q1 24 | 31.2% | 26.5% |
| Q4 25 | -20.9% | -164.1% | ||
| Q3 25 | -11.5% | -166.1% | ||
| Q2 25 | -21.8% | -122.7% | ||
| Q1 25 | -14.6% | -106.5% | ||
| Q4 24 | -21.7% | -144.1% | ||
| Q3 24 | -13.1% | -48.0% | ||
| Q2 24 | -13.6% | -48.6% | ||
| Q1 24 | -17.9% | -34.4% |
| Q4 25 | -25.0% | -176.6% | ||
| Q3 25 | -9.4% | -155.3% | ||
| Q2 25 | -18.8% | 623.4% | ||
| Q1 25 | -13.3% | -86.5% | ||
| Q4 24 | -22.5% | -225.2% | ||
| Q3 24 | -14.2% | -43.7% | ||
| Q2 24 | -5.3% | -65.2% | ||
| Q1 24 | -17.0% | -73.3% |
| Q4 25 | — | $-0.85 | ||
| Q3 25 | $-0.54 | $-0.61 | ||
| Q2 25 | $-0.82 | $3.72 | ||
| Q1 25 | $-0.44 | $-0.77 | ||
| Q4 24 | $49.77 | $-1.93 | ||
| Q3 24 | $-11.61 | $-0.50 | ||
| Q2 24 | $-43.48 | $-0.68 | ||
| Q1 24 | $-2.00 | $-1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $81.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.0M | $112.9M |
| Total Assets | $30.1M | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $81.8M | ||
| Q3 25 | — | $96.8M | ||
| Q2 25 | — | $117.6M | ||
| Q1 25 | — | $35.9M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | — | $45.8M | ||
| Q1 24 | — | $63.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | — | $103.1M | ||
| Q3 24 | — | $4.9M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | — | $123.1M |
| Q4 25 | $23.0M | $112.9M | ||
| Q3 25 | $24.2M | $133.1M | ||
| Q2 25 | $25.7M | $149.2M | ||
| Q1 25 | $22.7M | $3.7M | ||
| Q4 24 | $23.5M | $-11.7M | ||
| Q3 24 | $25.0M | $30.8M | ||
| Q2 24 | $23.5M | $40.3M | ||
| Q1 24 | $24.8M | $52.5M |
| Q4 25 | $30.1M | $211.0M | ||
| Q3 25 | $31.5M | $224.3M | ||
| Q2 25 | $32.0M | $239.5M | ||
| Q1 25 | $29.2M | $208.8M | ||
| Q4 24 | $30.6M | $193.6M | ||
| Q3 24 | $30.1M | $224.2M | ||
| Q2 24 | $29.3M | $230.8M | ||
| Q1 24 | $31.9M | $252.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 27.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 2.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6M | $-4.3M |
| Free Cash FlowOCF − Capex | $-1.6M | $-16.2M |
| FCF MarginFCF / Revenue | -18.9% | -102.1% |
| Capex IntensityCapex / Revenue | 0.0% | 75.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | $-92.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.6M | $-4.3M | ||
| Q3 25 | $-727.8K | $-12.0M | ||
| Q2 25 | $-1.3M | $-35.1M | ||
| Q1 25 | $-1.7M | $-8.4M | ||
| Q4 24 | $-3.4M | $-19.2M | ||
| Q3 24 | $-1.4M | $14.0M | ||
| Q2 24 | $-4.6M | $-4.4M | ||
| Q1 24 | $-3.2M | $-8.8M |
| Q4 25 | $-1.6M | $-16.2M | ||
| Q3 25 | $-735.8K | $-20.4M | ||
| Q2 25 | $-1.4M | $-38.7M | ||
| Q1 25 | $-1.7M | $-17.3M | ||
| Q4 24 | $-3.5M | $-24.3M | ||
| Q3 24 | $-1.9M | $5.1M | ||
| Q2 24 | $-5.6M | $-9.9M | ||
| Q1 24 | $-3.2M | $-15.9M |
| Q4 25 | -18.9% | -102.1% | ||
| Q3 25 | -7.8% | -161.3% | ||
| Q2 25 | -15.2% | -201.7% | ||
| Q1 25 | -19.3% | -72.6% | ||
| Q4 24 | -36.6% | -112.2% | ||
| Q3 24 | -22.2% | 17.8% | ||
| Q2 24 | -59.7% | -39.0% | ||
| Q1 24 | -43.1% | -45.7% |
| Q4 25 | 0.0% | 75.1% | ||
| Q3 25 | 0.1% | 66.2% | ||
| Q2 25 | 1.7% | 18.8% | ||
| Q1 25 | 0.1% | 37.3% | ||
| Q4 24 | 1.1% | 23.5% | ||
| Q3 24 | 6.1% | 31.2% | ||
| Q2 24 | 10.5% | 21.8% | ||
| Q1 24 | 0.8% | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
